These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11998611)

  • 1. Understanding peripheral neuropathy in patients with cancer: background and patient assessment.
    Sweeney CW
    Clin J Oncol Nurs; 2002; 6(3):163-6. PubMed ID: 11998611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.
    Corso A; Mangiacavalli S; Varettoni M; Pascutto C; Zappasodi P; Lazzarino M
    Leuk Res; 2010 Apr; 34(4):471-4. PubMed ID: 19674790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient guide to peripheral neuropathy.
    Almadrones LA; Arcot R
    Oncol Nurs Forum; 1999 Sep; 26(8):1359-60. PubMed ID: 10497775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical challenges: chemotherapy-induced peripheral neuropathy.
    Paice JA
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.
    Nurgalieva Z; Xia R; Liu CC; Burau K; Hardy D; Du XL
    Am J Ther; 2010; 17(2):148-58. PubMed ID: 19417586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of peripheral neuropathy in diabetic patients with cancer.
    Visovsky C; Meyer RR; Roller J; Poppas M
    Clin J Oncol Nurs; 2008 Apr; 12(2):243-7. PubMed ID: 18390460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.
    Glendenning JL; Barbachano Y; Norman AR; Dearnaley DP; Horwich A; Huddart RA
    Cancer; 2010 May; 116(10):2322-31. PubMed ID: 20225230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study.
    Almadrones L; McGuire DB; Walczak JR; Florio CM; Tian C
    Oncol Nurs Forum; 2004 May; 31(3):615-23. PubMed ID: 15146227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic complications of cancer chemotherapy.
    Sul JK; Deangelis LM
    Semin Oncol; 2006 Jun; 33(3):324-32. PubMed ID: 16769421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy related to chemotherapy.
    Wilkes G
    Semin Oncol Nurs; 2007 Aug; 23(3):162-73. PubMed ID: 17693343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
    Smith EM; Cohen JA; Pett MA; Beck SL
    Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
    Badros A; Goloubeva O; Dalal JS; Can I; Thompson J; Rapoport AP; Heyman M; Akpek G; Fenton RG
    Cancer; 2007 Sep; 110(5):1042-9. PubMed ID: 17654660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.
    Postma TJ; Aaronson NK; Heimans JJ; Muller MJ; Hildebrand JG; Delattre JY; Hoang-Xuan K; Lantéri-Minet M; Grant R; Huddart R; Moynihan C; Maher J; Lucey R;
    Eur J Cancer; 2005 May; 41(8):1135-9. PubMed ID: 15911236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
    Wickham R
    Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced peripheral neuropathy.
    Hilkens PH; ven den Bent MJ
    J Peripher Nerv Syst; 1997; 2(4):350-61. PubMed ID: 10975744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy.
    Argyriou AA; Polychronopoulos P; Koutras A; Xiros N; Petsas T; Argyriou K; Kalofonos HP; Chroni E
    Eur J Cancer Care (Engl); 2007 May; 16(3):231-7. PubMed ID: 17508942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy.
    Visovsky C; Collins M; Abbott L; Aschenbrenner J; Hart C
    Clin J Oncol Nurs; 2007 Dec; 11(6):901-13. PubMed ID: 18063548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background noise: the experience of chemotherapy-induced peripheral neuropathy.
    Bakitas MA
    Nurs Res; 2007; 56(5):323-31. PubMed ID: 17846553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.